ArticleClinical case reports2025
A Case Report of HIV-Associated Pituitary Lymphoma and Review of the Literature.
Article in Clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Pituitary T-lymphoblastic lymphoma combined with pituitary adenoma: a rare case report.Frontiers in oncology · 2026Article
- A Case Report of HIV-Associated Pituitary Lymphoma and Review of the Literature.Clinical case reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary saddle region tumors are the most commonly pituitary adenomas: They account for more than 90% of all saddle region tumors. Primary central nervous system lymphoma (PCNSL) lesions are relatively rare and are usually found around the ventricles. Reports of PCNSL lesions located in the saddle region are even rarer. We report a rare case of PCNSL originating from the pituitary-pituitary stalk-mammillary body region in a 33-year-old man. Clinical manifestations included progressive endocrine abnormalities and cavernous sinus syndrome. His initial symptoms consisted of fatigue, nausea, vomiting, and diplopia. Endocrine investigations revealed anterior pituitary hypopituitarism, with secondary hypothyroidism, hypogonadism, and adrenal insufficiency. Magnetic resonance imaging (MRI) showed an enhancing lesion in the pituitary stalk and pituitary gland involving the right cavernous sinus, along with loss of the posterior pituitary's T1 hyperintensity. The initial diagnosis at the external hospital was nonbacterial inflammatory pituitary disease. After treatment with methylprednisolone, some symptoms improved, and MRI scans indicated a slight reduction in lesion size. However, the diplopia did not resolve. Two weeks after steroid withdrawal, the patient's symptoms worsened. Upon referral to our hospital, he tested positive for HIV, and follow-up MRI demonstrated lesion enlargement with necrosis and hemorrhagic infarction, as well as reappearance of the posterior pituitary T1 hyperintensity. Following hormone replacement therapy, endoscopic transsphenoidal surgery was performed, and histopathological examination confirmed B-cell lymphoma.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.